CP-101537

• 产品号: PZ0107
• CAS号: 134575-17-0
• 分子式: C10H18N2O2
• 分子量: 198.26212
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: CP-101537
• IUPAC标准名: tert-butyl N-[(1R,5S,6R)-3-azabicyclo[3.1.0]hexan-6-yl]carbamate
• IUPAC传统名: tert-butyl N-[(1R,5S,6R)-3-azabicyclo[3.1.0]hexan-6-yl]carbamate
• 别名: MN-2633; N-(1a,5a,6a)-3-Azabicyclo[3.1.0]hex-6-yl-carbamic acid 1,1-dimethylethyl ester; PF-3339644

产品登记号

• EC号: 429-170-8
• CAS号: 134575-17-0

产品性质

• Empirical Formula (Hill Notation): C10H18N2O2
• 纯度: ≥98% (HPLC)
• 外观: white to off-white powder
• 溶解度: DMSO: >20 mg/mL
• GHS警示词: Danger
• GHS危险声明: H302-H317-H318-H373
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• GHS警示性声明: P280-P305 + P351 + P338
• 危险公开号: 22-41-43-48/22
• 安全公开号: 22-26-36/37/39
• 保存温度: 2-8°C
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
CP-101537 is a MMP inhibitor, candidate drug for myocardial infarction therapy, and antibacterial.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.

详细说明 (简体中文)

Biochem/physiol Actions
CP-101537 is a MMP inhibitor, candidate drug for myocardial infarction therapy, and antibacterial.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.